IRIS

Re: "A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: A randomized trial"

Pedrazzoli, Paolo
2009-01-01
2009
The Oncology category covers resources on the etiology, prevention, diagnosis, and treatment of cancer such as chemotherapy, radiation and gene therapy. Cancer specialties such as gynecologic oncology, neuro-oncology, surgical oncology, radiological oncology, oral oncology and dermatological oncology are also included.
JOURNAL OF THE NATIONAL CANCER INSTITUTE
no
2-s2.0-58549118952
Inglese
Internazionale
STAMPA
101
1
67
67
1
19116385
Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Small Cell Lung Carcinoma; Treatment Outcome; Cancer Research; Oncology
no
2
info:eu-repo/semantics/article
262
Bregni, Marco; Pedrazzoli, Paolo
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1228765
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact